Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review
  • Published Date:
    Mar 2011
  • Source:
    Curr Drug Abuse Rev. 2011; 4(1):28-41
  • Language:
    English
Filetype[PDF-90.25 KB]


Details:
No Related Documents.
You May Also Like:
  1. Evidence-based strategies for preventing opioid overdose : what’s working in the United States : an introduction for public heath, law enforcement, local organizations, and others striving to serve their community
    Personal Author:
    Carroll, Jennifer J.; Green, Traci C.; Noonan, Rita K.;
    Corporate Authors:
    National Center for Injury Prevention and Control (U.S.)
    Published Date:
    2018
    Description:
    This document is to assist community leaders, local and regional organizers, non-profit groups, law enforcement, public health, and members of the public in understanding and navigating effective strategies to prevent opioid overdose in their communi...
    File Type:
    Filetype[PDF - 11.38 MB]
  2. Provider Perceptions of System-Level Opioid Prescribing and Addiction Treatment Policies
    Personal Author:
    Haffajee, Rebecca L.; French, Cecelia A.;
    Published Date:
    February 04 2019
    Source:
    Curr Opin Psychol. 30:65-73
    Description:
    Stakeholders have implemented a multitude of system-level policies to address the U.S. opioid overdose epidemic. Because opioid prescribing partly fueled the crisis and because prescribing of medications for opioid addiction treatment is a key preven...
    File Type:
    Filetype[PDF - 415.49 KB]
  3. Addressing Prescription Drug Abuse in the United States: Current Activities and Future Opportunities
    Corporate Authors:
    Department of Health and Human Services (U.S.).
    Published Date:
    03/18/2014
    Description:
    The United States is in the midst of an unprecedented drug overdose epidemic. Drug overdose death rates have increased five-fold since 1980.1 By 2009, drug overdose deaths outnumbered deaths due to motor vehicle crashes for the first time in the U.S....
    File Type:
    Filetype[PDF - 985.56 KB]
  4. Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment
    Personal Author:
    Haffajee, Rebecca L.; Bohnert, Amy S.B.; Lagisetty, Pooja A.;
    Published Date:
    June 2018
    Source:
    Am J Prev Med. 54(6 Suppl 3):S230-S242
    Description:
    At least 2.3 million people in the U.S. have an opioid use disorder, less than 40% of whom receive evidence-based treatment. Buprenorphine used as part of medication-assisted treatment has high potential to address this gap because of its approval fo...
    File Type:
    Filetype[PDF - 365.78 KB]
  5. Notes from the Field: Emergency Visits for Complications of Injecting Transmucosal Buprenorphine Products — United States, 2016–2018
    Personal Author:
    Tanwar, Sukarma; Geller, Andrew I.; Lovegrove, Maribeth C.; Budnitz, Daniel S.;
    Published Date:
    August 14 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(32):1102-1103
    File Type:
    Filetype[PDF - 67.42 KB]